journal article·1995-09

Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution

Jamila Toufik, Denis Labarre

Biomaterials· Volume 16· Issue 14
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (19)

Show source-provided references
1. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes10.1172/JCI108710 ↗
2. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces10.4049/jimmunol.123.3.1388 ↗
3. Complement activation during hemodialysis: clinical observations, proposed mechanisms and theoretical implications10.1111/j.1525-1594.1984.tb04291.x ↗
4. Ex vivo biocompatibility evaluation of a new modified cellulose membrane10.1111/j.1525-1594.1987.tb02647.x ↗
5. Evaluation de la biocompatibilité d'une nouvelle membrane cellulosique par l'étude du système du complément et de l'histaminolibération
6. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation10.1111/j.1525-1594.1987.tb02648.x ↗
7. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives10.1016/0161-5890(88)90064-8 ↗
8. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups of nonactivating surfaces10.1002/eji.1830191126 ↗
9. Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum10.1016/0142-9612(88)90047-6 ↗
10. Specific antibodies enhance alternative complement pathway activation by Cuprophan10.1093/ndt/6.3.193 ↗
11. Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum10.1016/0142-9612(92)90024-I ↗
12. Complement and complement fixation
13. Techniques and significance of C3a and C5a measurements
14. Regulation by sulphonate groups of complement activation induced by hydroxymethyl groups on polystyrene surfaces10.1016/0142-9612(93)90024-V ↗
15. Specific interactions of polystyrene biomaterials with factor D of human complement10.1016/0142-9612(93)90065-A ↗
16. Interactions of functionalized polystyrene derivatives with the complement system in human serum10.1163/156856291X00034 ↗
17. Complement activation by hydroxyethyl methacrylate-ethyl methacrylate copolymers10.1002/jbm.820210703 ↗
18. Adsorption of unactivated complement proteins by hemodialysis membranes10.1016/S0272-6386(89)80147-7 ↗
19. Modulation of the formation of the human amplification C3 convertase of complement by polycations